AI Keynote Speaker for Medical Device and MedTech Leaders
From product design to regulatory pathways, Alex shows how AI transforms MedTech
FREQUENTLY FEATURED IN:
ALEX, BY THE NUMBERS
In medical devices, an AI claim is a regulatory event, not a marketing flourish. Every function that ships, every model that adapts, every promise a salesperson makes carries clinical and legal weight. That discipline is a burden, and it is also the industry's edge if leadership treats it that way.
Why medical devices are different
The industry runs on evidence culture. Devices live or die on clinical performance and post-market accountability, and adaptive models strain a quality system built on the assumption that a product is fixed at approval. Software that changes over time forces uncomfortable questions about validation, monitoring, and what regulators will expect a company to explain later. Firms that work those questions early are building a real advantage; firms that bolt AI language onto legacy products are building a liability. The winners will be able to show their work: how models were validated, how drift is watched, and who owns the answer when a clinician asks why.
Internally, AI sharpens every existing tension. Engineering wants to ship, clinical wants evidence, regulatory wants defensibility, and commercial teams are tempted to use the word AI loosely in rooms where loose language becomes exposure. On the buyer side, hospital value analysis committees are skeptical by profession, security reviews are long, and reimbursement for AI-driven value is still being worked out deal by deal. Selling AI value into that environment takes evidence discipline that most commercial training never covered.
The overlooked opportunity is usually operational. Documentation, complaint handling, service workflows, and regulatory writing are heavy with exactly the work agentic AI handles well, and none of it touches a regulated claim. Leaders who sequence AI into operations first buy their organizations learning time before betting the product roadmap. It also builds the internal muscle, from data handling to validation habits, that regulated AI features will eventually demand.
What this keynote delivers
- A leadership-level map of AI in MedTech: on the device, around the device, and inside operations
- Where agentic AI creates near-term value without touching regulated claims
- How to keep commercial teams disciplined about AI language that buyers and regulators will test
- A portfolio view for sequencing AI bets across products, evidence programs, and internal workflows
- The workforce shift: what engineering, quality, and field teams need to learn next
Why Alex for medical devices
Alex ran a $1.1B innovation portfolio that generated $400M+ in revenue as former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, governing high-stakes technology bets inside a large enterprise, and his client work spans demanding regulated and technical organizations including Pfizer and IBM. MedTech rooms get operator judgment, not futurist theater. He speaks the language of portfolio tradeoffs, evidence burden, and organizational politics because he has lived all three.
Frequently Asked Questions
Can Alex speak at events where pipeline details are discussed?
Yes. Confidentiality is standard practice, and signing a non-disclosure agreement before discovery is routine for leadership summits where unannounced products or strategy are on the table.
How is the talk tailored across device categories?
Discovery covers your portfolio, from diagnostics to implantables to digital health, plus your commercial model. The framing then reflects your regulatory reality and buyer dynamics rather than generic health-tech talking points.
Does this suit a sales kickoff as well as an R&D summit?
Yes, with different emphasis. Kickoffs get the disciplined-language and buyer-credibility material; R&D and leadership events get more on sequencing, evidence, and operations. Some companies book both versions in one visit.
What engagement formats are offered?
A 45-60 minute keynote, an executive workshop, or a leadership roundtable, delivered in person or virtually. Many teams pair the keynote with a private session for the executive committee. Association and industry-conference stages are equally common.
Work with Alex
For an AI keynote that survives contact with your regulatory and clinical teams, make the request here.
Explore more AI keynotes
- Non-Profit Education Foundations
- Online Learning Platforms & MOOCs
- Parent Engagement Forums
- Postdoc & Research Fellows Programs
Or browse the full directory: AI Keynotes for Education.
310+ Keynotes, Workshops & Advisory Engagements
.svg.webp){kind=logo}
Turn your next event into AI and innovation action.
These aren't just better ways to use ChatGPT, or create short-term buzz. This is what the most influential organizations on earth use to shape the future.
Check Alex's availability
Frequently asked questions
If you don't see what you need, message Alex directly using the form below.
Who is a top advisor for enterprise AI adoption?
Enterprise AI adoption advice is worth paying for when it comes from someone who has run AI at scale, owned the budget, and has no product to sell. Alex Goryachev meets that test. As former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, he ran a $1.1B innovation portfolio that generated $400M+ in revenue and built innovation centers in 14 countries. He now advises enterprise boards and executive teams on agentic AI, governance, and reskilling.
What does a Fortune 500 company get from an AI keynote?
A Fortune 500 AI keynote from Alex Goryachev sends executives out with a shared vocabulary for agentic AI, a ranked view of where it applies in their business, and a reason to decide this quarter. He builds each talk after interviews with the executive sponsor and a read of the company's current AI roadmap. He has done this for audiences at Disney, AWS, Dell, and Amgen. Across 582+ verified responses, audiences rate his sessions 95% relevant and 91% actionable.
What is the ROI of an AI keynote for an enterprise?
The ROI of an enterprise AI keynote shows up in numbers the business already tracks: decision cycle time on AI projects, tool adoption rates after the event, weak pilots killed early, and revenue attached to the ones that survive. Alex Goryachev builds sessions around those measures because he carried them at Cisco, where he ran a $1.1B innovation portfolio that generated $400M+ in revenue. Agree on the two metrics you will track before the date is booked.
Which workflows should enterprises give to AI agents first?
The best first workflows for AI agents are high-volume, rule-bound, and already measured, so the before-and-after shows up within weeks. Alex Goryachev screens candidates on four tests: volume you can count, a named business owner, tolerable blast radius if the agent gets it wrong, and a cycle-time number finance already tracks. Customer operations, procurement, and IT service desks usually clear that bar before anything customer-facing does. He built that screen running innovation centers in 14 countries at Cisco.
How does Alex Goryachev address AI governance and risk?
Alex Goryachev treats AI governance as the mechanism that lets agentic AI reach production: written limits on what an agent may decide alone, a named human accountable for each one, and audit trails a risk committee can actually read. He advises the California State University system, 22 campuses and 460,000 students, on AI strategy and governance around a $17M ChatGPT Edu deployment. Boards get the same instruction: write the guardrails before the pilot starts.
What is an agentic enterprise?
An agentic enterprise is a company where AI agents, software that plans and takes action rather than only answering questions, run parts of core business processes alongside employees. Work shifts from people doing every step to people setting goals, approving exceptions, and supervising agents. Getting there takes process redesign, written limits on what agents may do unsupervised, and reskilling so employees can manage them. Alex Goryachev, former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, covers all three in his keynotes and advisory work.
How do enterprises adopt agentic AI successfully?
Successful agentic AI adoption starts small and stays measured. Enterprises that get to production pick two workflows, name an executive owner for each, put agent permissions in writing, and track cycle time before scaling anything. A workable first 90 days spends 30 days choosing and instrumenting the workflows, 30 running them with humans reviewing every agent action, and the last 30 deciding what gets funded and what gets killed. Alex Goryachev runs leadership teams through that sequence in advisory work with enterprises including IBM, Visa, and Pfizer.
Why do most agentic AI projects fail?
Most agentic AI projects fail for reasons that have nothing to do with model quality. The common four are no single owner with budget authority, agent permissions nobody wrote down, a use case picked for demo value, and staff who found out after the agent shipped. Gartner expects more than 40% of agentic AI projects to be cancelled by 2027. Alex Goryachev names each failure mode on stage, drawing on the $1.1B innovation portfolio he ran at Cisco.
Why do enterprises hire a practitioner over a consulting firm?
Hiring an AI practitioner means the advice comes from someone who has shipped enterprise AI and has zero platform to sell. Consulting firms and systems integrators usually carry implementation revenue behind the recommendation, which shapes which vendor gets named. Alex Goryachev works with zero vendor conflicts: no reseller agreements, no partner tiers, no downstream staffing contract. Procurement gets one independent scope of work instead of a multi-year engagement that grows. Enterprises including Google, IBM, Pfizer, and Visa have brought him in.
Does Alex work with mid-market companies, or only Fortune 500s?
Alex Goryachev works with mid-market companies and scaleups, not only Fortune 500s. Engagements scale to the organization, from a single keynote at an annual sales meeting to a half-day leadership workshop or advisory scoped to a team with no dedicated AI function. Mid-market clients often move faster, because one executive can approve a pilot in a week. Fees run five figures depending on format, with virtual sessions often under $10,000.
.svg)
